skip to main content

Our M&A lawyers are among the most experienced and effective in the world. We represent many of the world's largest publicly traded and privately held companies, as well as leading private equity firms, hedge funds, financial advisors and other financial institutions and investors on their most important merger, acquisitions and takeover transactions.

Smith & Nephew to Acquire Osiris Therapeutics

Paul, Weiss is representing UK-based medical technology business Smith & Nephew plc in its all-cash $660 million acquisition of U.S.-based regenerative medicine maker Osiris Therapeutics, Inc. The deal values U.S.-based Osiris at $19.00 per share. The transaction is expected to close in the second quarter of 2019.

The Paul, Weiss team includes corporate partners Scott Barshay and David Klein and counsel Patricia Vaz de Almeida; employee benefits partner Lawrence Witdorchic; tax partners Patrick Karsnitz and Jeffrey Samuels and counsel Alyssa Wolpin; intellectual property partner Claudine Meredith-Goujon; real estate partner Mitchell Berg; antitrust counsel Marta Kelly; international trade counsel Richard Elliott; environmental counsel William O’Brien; and litigation partners Daniel Toal and Andrew Forman.

March 12, 2019

© 2019 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy